Our position as one of the top cardiovascular research hubs in the UK is facilitated by close associations with the Heart Centre of Barts Health NHS Trust, serving 6m people across North and East London, and reflected by support from diverse funders including the National Institute for Health Research (NIHR), British Heart Foundation (BHF) and the European Research Council (ERC).
NIHR Biomedical Research Centre
£6.5m was awarded to establish a cardiovascular Biomedical Research Centre (BRC), providing an integrated discovery science and treatment centre. World-leading experts focus on inherited heart disease to address unmet clinical need, and by partnering with the technology industry and other academics from across the globe, the BRC encourages the development of new medical devices to improve and save lives.
Cardiovascular devices innovation and development hub
An award from the European Regional Development Fund has helped establish our ‘one stop’ innovation and development hub for new cardiovascular devices. The centre, which is the only one like it in the world, offers new partnerships and a closer working relationship with industry to test ideas. The hub is multi-disciplinary in its concept, bringing clinicians and bioengineers to solve problems together and take innovative ideas from concept to first human clinical trials.
BHF Accelerator Award
In 2019, we started our BHF Accelerator Award (£1 million) to study the etiopathogenesis and therapeutic opportunities for inflammatory syndromes of the heart, including myocarditis and other cardiomyopathies.
Close links with cardiovascular research charities
We have a long-established working relationship with the UK’s major funder of cardiovascular research, the British Heart Foundation (BHF) with several programmes, projects and fellowships. Professor Federica Marelli-Berg is the official BHF Professor of Cardiovascular Immunology, due to her leading work in the role that inflammation plays in heart disease. Our BHF 4-year doctoral training programme on cardiac and vascular research has been renewed for the second time (2021-2025).